Changes in the pattern of brain-derived neurotrophic factor immunoreactivity in the rat brain after acute and subchronic haloperidol treatment

Synapse

Volumn 39, Issue 1, 2001, Pages 70-81

  Dawson, Niamh M ^a   Hamid, Emad H ^b   Meredith, Gloria E ^b,c  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

Extended amygdala; Neurotrophin; Nucleus accumbens; Ventral tegmental area

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; HALOPERIDOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL PLASTICITY; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

AMYGDALA; ANIMALS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; DRUG ADMINISTRATION SCHEDULE; DYSKINESIA, DRUG-INDUCED; HALOPERIDOL; HIPPOCAMPUS; LIMBIC SYSTEM; MALE; NEOSTRIATUM; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; SEPTAL NUCLEI; SUBSTANTIA NIGRA; VENTRAL TEGMENTAL AREA;

EID: 0035218087     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2396(20010101)39:1<70::AID-SYN10>3.0.CO;2-J     Document Type: Article

References (71)

1. The contribution of the amygdala to normal and abnormal emotional states
2. Theories of basal forebrain organization and the 'emotional motor system'
3. Amygdala and extended amygdala
4. Neurotrophin trafficking by anterograde transport
5. Anterograde transport of brain-derived neurotrophic factor and its role in the brain
6. Haloperidol-induced plasticity of axon terminals in rat substantia nigra
7. The effects of haloperidol on synaptic patterns in the rat striatum
8. Gating of BDNF-induced synaptic potentiation by cAMP
9. Acute and chronic haloperidol treatment: Comparison of effects on nigral dopaminergic cell activity
10. Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: Evidence for anterograde axonal transport
11. Actions of clozapine and haloperidol on extracellular levels of excitatory amino acids in the prefrontal cortex and striatum of conscious rats
12. Haloperidol regulation of brain-derived neurotrophic factor in the extended amygdala and hippocampus of the rat
13. Modification of dendritic morphology in nucleus accumbens' shell and core neurons following chronic haloperidol treatment as a basis for the development of vacuous chewing movements
14. Pharmacological characterization of dopamine systems in the nucleus accumbens shell and core
15. Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress
16. A molecular and cellular theory of depression
17. Alterations in mRNA levels of D2 receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptic-induced dyskinesias
18. Effects of chronic neuroleptic treatment on dopamine release: Insights from studies using 3-methoxytyramine
19. The effects of acute and chronic haloperidol treatment on dopamine release mediated by the medial forebrain bundle in the striatum and nucleus accumbens
20. Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol
21. Treatment of schizophrenia: A clinical and preclinical evaluation of neuroleptic drugs
22. Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus
23. Brain-derived neurotrophic factor and neurotrophin-3 mRNA are expressed in ventral midbrain regions containing dopaminergic neurons
24. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia
25. Induction of depolarization block in midbrain dopamine neurons by repeated administration of haloperidol: Analysis using in vivo intracellular recordings
26. Neurotrophic factors in memory disorders
27. Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor
28. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra
29. 1 receptors and their desensitization after chronic treatment
30. Neuroanatomical localization of D1 versus D2 receptors: Similar organization in the basal ganglia of the rat, cat, and human and disparate organization in the cortex and limbic system
31. The circuitry mediating the translation of motivational stimuli into adaptive responses
32. Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus
33. A requirement for local protein synthesis in neurotrophin-induced hippocampal synaptic plasticity
34. Time course of antipsychotic effects of neuroleptic drugs
35. Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3
36. Emotional memory systems in the brain
37. Bilateral regulation of glutamate tissue and extracellular levels in caudate-putamen by midbrain dopamine neurons
38. Activity-dependent and hormonal regulation of neurotrophin mRNA levels in the brain: Implications for neuronal plasticity
39. Brain-derived neurotrophic factor antisense oligonucleotide impairs memory retention and inhibits long-term potentiation in rats
40. Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors: Interactions with amphetamine
41. Release-regulating D-2 dopamine receptors are located on striatal glutamatergic nerve terminals
42. Opposing roles for endogenous BDNF and NT-3 in regulating cortical dendritic growth
43. Ultrastructural changes in dynorphinergic terminals of nucleus accumbens in rats that display neuroleptic-induced vacuous chewing movements
44. Regional, reversible ultrastructural changes in rat brain with chronic neuroleptic treatment
45. Coadministration of haloperidol and SCH-23390 prevents the increase in 'perforated' synapses due to either drug alone
46. Effect of haloperidol and clozapine on the density of 'perforated' synapses in caudate, nucleus accumbens, and medial prefrontal cortex
47. Correlation of vacuous chewing movements with morphological changes in rats following 1-year treatment with haloperidol
48. Morphological changes in Met5-enkephalin-immunoreactive synaptic boutons in the rat neostriatum after haloperidol decanoate treatment
49. Striatal dopamine efflux in rats with haloperidol-induced depolarization block in substantia nigra dopamine neurons
50. Intrastriatal infusions of brain-derived neurotrophic factor: Retrograde transport and colocalization with dopamine containing substantia nigra neurons in rat
51. Dopaminergic stimulation up-regulates the in vivo expression of brain-derived neurotrophic factor (BDNF) in the striatum
52. Acute versus chronic haloperidol: Relationship between tolerance to catalepsy and striatal and accumbens dopamine, GABA and acetylcholine release
53. Neurotrophin expression in rat hippocampal slices: A stimulus paradigm inducing LTP in CA1 evokes increases in BDNF and NT-3 mRNAs
54. Widespread expression of BDNF but not NT-3 by target areas of basal forebrain cholinergic neurons
55. Ultrastructural correlates of haloperidol-induced oral dyskinesias in rat striatum
56. A clinical guide to antipsychotic drugs
57. Changes in striatal dopamine release and metabolism during and after subchronic haloperidol administration in rats
58. Differential expression of c-fos mRNA in rat prefrontal cortex, striatum, n. accumbens and lateral septum after typical and atypical antipsychotics: An in situ hybridization study
59. TrkB signaling modulates spine density and morphology independent of dendrite structure in cultured neonatal Purkinje cells
60. The changing scene of neurotrophic factors
61. Anterograde transport of neurotrophins and axodendritic transfer in the developing visual system
62. The effects of chronic haloperidol administration on GABA-immunoreactive axon terminals in rat medial prefrontal cortex
63. Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: Phenomenology, pathophysiology and putative relationship to tardive dyskinesia
64. The status of late-onset vacuous chewing/perioral movements during long-term neuroleptic treatment in rodents: Tardive dyskinesia or dystonia?
65. Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations
66. Dopaminergic modulation of glutamate release in striatum as measured by microdialysis
67. Optimal effectiveness of BDNF for fetal nigral transplants coincides with the ontogenetic appearance of BDNF in the striatum
68. Activity dependent regulation of BDNF and NGF mRNAs in the rat hippocampus is mediated by non-NMDA glutamate receptors
69. Endogenous brain-derived neurotrophic factor is anterogradely transported in primary sensory neurons
70. An improved procedure for the immunohistochemical localization of nerve growth factor-like immunoreactivity